FDA — authorised 10 November 2020
- Application: NDA213135
- Marketing authorisation holder: AZURITY
- Local brand name: SUTAB
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Sutab in United States
FDA authorised Sutab on 10 November 2020
Marketing authorisations
FDA
- Status: approved
Sutab in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Sutab approved in United States?
Yes. FDA authorised it on 10 November 2020; FDA has authorised it.
Who is the marketing authorisation holder for Sutab in United States?
AZURITY holds the US marketing authorisation.